Development and biocompatibility of a novel corrodible fluoride-coated magnesium-calcium alloy with improved degradation kinetics and adequate mechanical properties for cardiovascular applications

Journal of Biomedical Materials Research - Part A

Volumn 93, Issue 2, 2010, Pages 763-775

  Drynda, Andreas ^a   Hassel, Thomas ^b   Hoehn, René ^a   Perz, Angela ^a   Bach, Friedrich Wilhelm ^b   Peuster, Matthias ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b LEIBNIZ UNIVERSITY HANNOVER   (Germany)

Author keywords

Biocorrosion; Calcium; Fluorine fluoride; Intravascular stent; Magnesium

Indexed keywords

BIOCORROSION; CARDIOVASCULAR APPLICATIONS; CARDIOVASCULAR STENTS; CYTOTOXIC EFFECTS; DECOMPOSITION KINETICS; DEGRADATION KINETICS; HUMAN SMOOTH MUSCLE CELLS; IN-VITRO; INCUBATION TIME; INTRAVASCULAR STENT; INTRAVASCULAR STENTS; MAGNESIUM-CALCIUM ALLOYS; METABOLIC ACTIVITY; ORTHOPEDIC IMPLANT; PHYSIOLOGICAL ENVIRONMENT; RAPID CORROSION; SMOOTH MUSCLE CELLS; SMOOTH MUSCLES; VASCULAR CELLS;

BIOCOMPATIBILITY; BIODEGRADATION; BIOMECHANICS; BLOOD VESSEL PROSTHESES; CALCIUM; CALCIUM ALLOYS; DEGRADATION; ENDOTHELIAL CELLS; FLUORINE; MAGNESIUM; MAGNESIUM ALLOYS; MECHANICAL PROPERTIES; METABOLISM; MUSCLE; SELF ASSEMBLY;

ALLOYS;

ALLOY; FLUORIDE; MAGNESIUM CALCIUM ALLOY; UNCLASSIFIED DRUG;

ARTICLE; BIOCOMPATIBILITY; CELL METABOLISM; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DEGRADATION KINETICS; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; SMOOTH MUSCLE FIBER;

ALLOYS; ANIMALS; CALCIUM; CELL SURVIVAL; CELLS, CULTURED; COATED MATERIALS, BIOCOMPATIBLE; CORROSION; ENDOTHELIAL CELLS; FLUORIDES; HUMANS; MAGNESIUM; MATERIALS TESTING; MYOCYTES, SMOOTH MUSCLE; STENTS; SURFACE PROPERTIES;

EID: 77950219251     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32582     Document Type: Article

References (31)

1. Sigwart U, Puel J, Mirkovitch V, Joffre F, Kappenberger L. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med 1987;316:701-706.
2. Mullins CE, O'Laughlin MP, Vick GW III, Mayer DC, Myers TJ, Kearney DL, Schatz RA, Palmaz JC. Implantation of balloon-expandable intravascular grafts by catheterization in pulmonary arteries and systemic veins. Circulation 1988; 77:188-199.
3. O'Laughlin MP, Perry SB, Lock JE, Mullins CE. Use of endovascular stents in congenital heart disease. Circulation 1991;83:1923-1939.
4. Okubo M, Benson LN. Intravascular and intracardiac stents used in congenital heart disease. Curr Opin Cardiol 2001;16:84-91.
5. Ryan MP, Williams DE, Chater RJ, Hutton BM, McPhail DS. Why stainless steel corrodes. Nature 2002;415:770-774.
6. Reclaru L, Lerf R, Eschler PY, Meyer JM. Corrosion behavior of a welded stainless-steel orthopedic implant. Biomaterials 2001;22:269-279.
7. Kraft CN, Diedrich O, Burian B, Schmitt O, Wimmer MA. Microvascular response of striated muscle to metal debris. A comparative in vivo study with titanium and stainless steel. J Bone Joint Surg Br 2003;85:133-141.
8. Carroll WM, Kelly MJ. Corrosion behavior of nitinol wires in body fluid environments. J Biomed Mater Res A 2003;67:1123-1130.
9. Heintz C, Riepe G, Birken L, Kaiser E, Chakfé N, Morlock M, Delling G, Imig H. Corroded nitinol wires in explanted aortic endografts: An important mechanism of failure? J Endovasc Ther 2001;8:248-253.
10. Peuster M, Fink C, von Schnakenburg C, Hausdorf G. Dissolution of tungsten coils does not produce systemic toxicity, but leads to elevated levels of tungsten in the serum and recanalization of the previously occluded vessel. Cardiol Young 2002;12:229-235.
11. Peuster M, Fink C, Wohlsein P, Bruegmann M, Günther A, Kaese V, Niemeyer M, Haferkamp H, Schnakenburg C. Degradation of tungsten coils implanted into the subclavian artery of New Zealand white rabbits is not associated with local or systemic toxicity. Biomaterials 2003;24:393-399.
12. Peuster M, Hesse C, Schloo T, Fink C, Beerbaum P, von Schnakenburg C. Long-term biocompatibility of a corrodible peripheral iron stent in the porcine descending aorta. Biomaterials 2006;27:4955-4962.
13. Williams D. New interests in magnesium. Med Device Technol 2006;17:9-10.
14. Witte F, Kaese V, Haferkamp H, Switzer E, Meyer-Lindenberg A, Wirth CJ, Windhagen H. In vivo corrosion of four magnesium alloys and the associated bone response. Biomaterials 2005;26:3557-3563.
15. Di Mario C, Griffiths H, Goktekin O, Peeters N, Verbist J, Bosiers M, Deloose K, Heublein B, Rohde R, Kasese V, Ilsley C, Erbel R. Drug-eluting bioabsorbable magnesium stent. J Interv Cardiol 2004;17:391-395.
16. Peeters P, Bosiers M, Verbist J, Deloose K, Heublein B. Preliminary results after application of absorbable metal stents in patients with critical limb ischemia. J Endovasc Ther 2005;12:1-5.
17. Drynda A, Deinet N, Braun N, Peuster M. Rare earth metals used in biodegradable magnesium-based stents do not interfere with proliferation of smooth muscle cells but do induce the upregulation of inflammatory genes. J Biomed Mater Res A 2009;91:360-369.
18. Waksman R, Pakala R, Kuchulakanti PK, Baffour R, Hellinga D, Seabron R, Tio FO, Wittchow E, Hartwig S, Harder C, Rohde R, Heublein B, Andreae A, Waldmann KH, Haverich A. Safety and efficacy of bioabsorbable magnesium alloy stents in porcine coronary arteries. Catheter Cardiovasc Interv 2006;68:607-617.
19. Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 1973;52:2745-2756.
20. Erbel R, Di Mario C, Bartunek J, Bonnier J, de Bruyne B, Eberli FR, Erne P, Haude M, Heublein B, Horrigan M, Ilsley C, Böse D, Koolen J, Lüscher TF, Weissmann N, Waksman R. Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: A prospective, non-randomised multicentre trial. Lancet 2007;369: 1869-1875.
21. Magnesium Elektron, Datasheet: 478, May 2006, Magnesium Elektron, UK. Available at: http://www.magnesium-elektron.com/data/downloads/DS478WroughtWE43. pdf.
22. Hirano S, Suzuki KT. Exposure, metabolism, and toxicity of rare earths and related compounds. Environ Health Perspect 1996;104(Suppl 1):85-95.
23. Nakamura Y, Tsumura Y, Tonogai Y, Shibata T, Ito Y. Differences in behavior among the chlorides of seven rare earth elements administered intravenously to rats. Fundam Appl Toxicol 1997;37:106-116.
24. Hassel T. Beitrag zur Entwicklung bioresorbierbarer implantatmaterialien auf magnesium-basis, Dissertation LU Hannover: Berichte aus dem IW Band 01/2008. ISBN 978-3-939026-90-7.
25. Krause C, Bormann D, Hassel T, Bach FW. Mechanical properties of degradable magnesium implants in dependence of the implantation duration. Magnesium technology in the global age. In: 45th Annual Conference of Metallurgists of CIM, QC, Canada, October 1-4, 2006. p 329-343.
26. Hassel T, Bach FW, Golovko A, Krause C. Investigation of the mechanical properties and the corrosion behaviour of low alloyed magnesium calcium alloys for use as absorbable biomaterial in the implant technique. Magnesium technology in the global age. In: 45th Annual Conference of Metallurgists of CIM, QC, Canada, October 1-4, 2006. p 359-370.
27. Hermawan H, Moravej M, Dubé D, Fiset M, Mantovani D. Degradation behaviour of metallic biomaterials for degradable stents. Adv Mater Res 2007;15-17:113-118.
28. Abrams SA, Atkinson SA. Calcium, magnesium, phosphorus and vitamin D fortification of complementary foods. J Nutr 2003;133:2994S-2999S.
29. Elin RJ. Magnesium: The fifth but forgotten electrolyte. Am J Clin Pathol 1994;102:616-622.
30. Konrad M, Weber S. Recent advances in molecular genetics of hereditary magnesium-losing disorders. J Am Soc Nephrol 2003;14:249-260.
31. Whitford GM. Intake and metabolism of fluoride. Adv Dent Res 1994;8:5-14.